Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 829-848 , October 2006

Contemporary concepts of inflammation, damage and repair in rheumatic diseases

References 

  1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361
  2. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85(3):307–310
  3. Feldmann M, Brennan FM, Williams RO, et al. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis. Best Practice & Research in Clinical Rheumatology. 2004;18(1):59–80
  4. Braun J, Sieper J. Biological therapies in the spondyloarthritides – the current state. Rheumatology. 2004;43(9):1072–1084
  5. Lories RJ, Luyten FP. Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targets. Clinical Rheumatology. 2001;20(1):3–9
  6. Lories RJ, Luyten FP. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine and Growth Factor Reviews. 2005;16(3):287–298
  7. Rau R, Herborn G, Wassenberg S. Healing of erosive changes in rheumatoid arthritis. Clinical and Experimental Rheumatology. 2004;22(5):S44–S49
  8. Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews. 2003;24(2):218–235
  9. Lafyatis R, Remmers EF, Roberts AB, et al. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-ß and retinoids. Journal of Clinical Investigation. 1989;83(4):1267–1276
  10. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and Rheumatism. 2001;44(8):1928–1942
  11. Edwards JC. Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Research. 2000;2(5):344–347
  12. Valencia X, Higgins JM, Kiener HP, et al. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. Journal of Experimental Medicine. 2004;200(12):1673–1679
  13. Lee D, Kien HP, Agarwal S, et al. Synovial cadherin-11. Arthritis Research and Therapy. 2004;6(supplement 3):96
  14. Kawaguchi J, Kii I, Sugiyama Y, et al. The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage. Journal of Bone and Mineral Research. 2001;16(2):260–269
  15. Hadeball B, Borchers A, Wedlich D. Xenopus cadherin-11 (Xcadherin-11) expression requires the Wg/Wnt signal. Mechanisms of Development. 1998;72(1–2):101–113
  16. Ahmed N, Sammons J, Carson RJ, et al. Effect of bone morphogenetic protein-6 on haemopoietic stem cells and cytokine production in normal human bone marrow. Cell Biology International. 2001;25(5):429–435
  17. Scharstuhl A, Vitters EL, van der Kraan PM, van Den Berg WB. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor ß/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis and Rheumatism. 2003;48(12):3442–3451
  18. Simkin PA. The musculoskeletal system: A. Joints. In:  Klippel JH,  Weyand CM,  Wortmann RL editor. Primer on the Rheumatic Diseases. Atlanta: Arthritis Foundation; 1997;p. 10–14
  19. Rhee DK, Marcelino J, Baker MA, et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. Journal of Clinical Investigation. 2005;115(3):622–631
  20. Dell'Accio F, De Bari C, Luyten FP. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis and Rheumatism. 2001;44(7):1608–1619
  21. Serra R, Johnson M, Filvaroff EH, et al. Expression of a truncated, kinase-defective TGF-ß type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. Journal of Cell Biology. 1997;139(2):541–552
  22. Rountree RB, Schoor M, Chen H, et al. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biology. 2004;2(11):e355
  23. Luyten FP, Dell'Accio F, De Bari C. Skeletal tissue engineering: opportunities and challenges. Best Practice & Research Clinical Rheumatology. 2001;15(5):759–769
  24. Luyten FP, Lories RJ, De Bari C, et al. Bone morphogenetic proteins and the synovial joint. In:  Vukicevic S,  Sampath KT editor. Progress in Inflammation Research. Berlin: Springer Verlag; 2004;p. 243–248
  25. Erlacher L, Ng CK, Ullrich R, et al. Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis and Rheumatism. 1998;41(2):263–273
  26. Tardif G, Hum D, Pelletier JP, et al. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis and Rheumatism. 2004;50(8):2521–2530
  27. Chubinskaya S, Merrihew C, Cs-Szabo G, et al. Human articular chondrocytes express osteogenic protein-1. Journal of Histochemistry and Cytochemistry. 2000;48(2):239–250
  28. Fukui N, Zhu Y, Maloney WJ, et al. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. Journal of Bone and Joint Surgery. American Volume. 2003;85A:59–66
  29. Seto H, Kamekura S, Miura T, et al. Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. Journal of Clinical Investigation. 2004;113(5):718–726
  30. Benjamin M, McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. Journal of Anatomy. 2001;199(Pt 5):503–526
  31. Lories RJU, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. Journal of Clinical Investigation. 2005;115(6):1571–1579
  32. Zvaifler NJ, Firestein GS. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis and Rheumatism. 1994;37(6):783–789
  33. Muller-Ladner U, Kriegsmann J, Franklin BN, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. American Journal of Pathology. 1996;149(5):1607–1615
  34. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Research. 2000;2(5):361–367
  35. Pap T, Aupperle KR, Gay S, et al. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis and Rheumatism. 2001;44(3):676–681
  36. Firestein GS, Echeverri F, Yeo M, et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(20):10895–10900
  37. Yamanishi Y, Boyle DL, Pinkoski MJ, et al. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. American Journal of Pathology. 2002;160(1):123–130
  38. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis?. Arthritis and Rheumatism. 1990;33(6):768–773
  39. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis?: II. T cell- independent mechanisms from beginning to end. Arthritis and Rheumatism. 2002;46(2):298–308
  40. Corr M, Zvaifler NJ. Mesenchymal precursor cells. Annals of the Rheumatic Diseases. 2002;61(1):3–5
  41. Buckley CD, Filer A, Haworth O, et al. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Annals of the Rheumatic Diseases. 2004;63(supplement 2):ii92–ii95
  42. Parsonage G, Filer AD, Haworth O, et al. A stromal address code defined by fibroblasts. Trends in Immunology. 2005;26(3):150–156
  43. Luyten FP. Mesenchymal stem cells in arthritis. In:  Panayi GS,  Firestein GS,  Wollheim FA editor. Rheumatoid Arthritis: Frontiers in Pathophysiology and Treatment. Oxford: Oxford University Press; 2006;pp. 551–559.
  44. Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford). 2003;42(supplement 2):ii11–ii16
  45. Walsh NC, Crotti TN, Goldring SR, Gravallese EM. Rheumatic diseases: the effects of inflammation on bone. Immunological Reviews. 2005;208:228–251
  46. Lipsky PE. Integrating biologic therapy into the comprehensive care of patients with rheumatoid arthritis. Journal of Rheumatology. Supplement. 2005;72:54–57
  47. Miossec P. Interleukin-17 in rheumatoid arthritis – if T cells were to contribute to inflammation and destruction through synergy. Arthritis and Rheumatism. 2003;48(3):594–601
  48. Lubberts E, Koenders MI, van Den Berg WB. The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Research and Therapy. 2004;7(1):29–37
  49. Gravallese EM, Manning C, Tsay A, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis and Rheumatism. 2000;43(2):250–258
  50. Haynes DR, Crotti TN, Loric M, et al. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford). 2001;40(6):623–630
  51. Haynes DR, Barg E, Crotti TN, et al. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology (Oxford). 2003;42(1):123–134
  52. Crotti TN, Smith MD, Weedon H, et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Annals of the Rheumatic Diseases. 2002;61(12):1047–1054
  53. Gravallese EM, Harada Y, Wang JT, et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. American Journal of Pathology. 1998;152(4):943–951
  54. Pettit AR, Ji H, von Stechow D, et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. American Journal of Pathology. 2001;159(5):1689–1699
  55. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999;402(6759):304–309
  56. Redlich K, Hayer S, Maier A, et al. Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis and Rheumatism. 2002;46(3):785–792
  57. Romas E, Sims NA, Hards DK, et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. American Journal of Pathology. 2002;161(4):1419–1427
  58. Jimenez-Boj E, Redlich K, Turk B, et al. Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. Journal of Immunology. 2005;175(4):2579–2588
  59. Gortz B, Hayer S, Redlich K, et al. Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. Journal of Bone and Mineral Research. 2004;19(6):990–998
  60. Wu Y, Liu J, Feng X, et al. Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis. Arthritis and Rheumatism. 2005;52(10):3257–3268
  61. van Den Berg WB, Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I. Best Practice & Research Clinical Rheumatology. 1999;13(4):577–597
  62. Mengshol JA, Vincenti MP, Coon CI, et al. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappa B – Differential regulation of collagenase 1 and collagenase 3. Arthritis and Rheumatism. 2000;43(4):801–811
  63. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Frontiers in Bioscience. 2006;11:529–543
  64. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 1986;322(6079):547–549
  65. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clinical and Experimental Immunology. 1989;75(2):306–310
  66. Seckinger P, Yaron I, Meyer FA, et al. Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6. Arthritis and Rheumatism. 1990;33(12):1807–1814
  67. Kane D, Jensen LE, Grehan S, et al. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction. Journal of Rheumatology. 2004;31(7):1274–1280
  68. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nature Immunology. 2005;6(12):1191–1197
  69. Han JH, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nature Immunology. 2005;6(12):1198–1205
  70. Goronzy JJ, Weyand CM. T-cell regulation in rheumatoid arthritis. Current Opinion in Rheumatology. 2004;16(3):212–217
  71. Shukunami C, Oshima Y, Hiraki Y. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochemical and Biophysical Research Communications. 2005;333(2):299–307
  72. Hayami T, Funaki H, Yaoeda K, et al. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. Journal of Rheumatology. 2003;30(10):2207–2217
  73. François RJ, Gardner DL, Degrave EJ, Bywaters EG. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis and Rheumatism. 2000;43(9):2011–2024
  74. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000;289(5477):265–270
  75. Johnson K, Polewski M, van Etten D, Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1−/− mice. Arteriosclerosis Thrombosis and Vascular Biology. 2005;25(4):686–691
  76. Williams CJ, Zhang Y, Timms A, et al. Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. American Journal of Human Genetics. 2002;71(4):985–991
  77. Espinoza LR, Espinoza CG, Cuellar ML, et al. Fibroblast function in psoriatic-arthritis. 2. Increased expression of ß-platelet-derived growth-factor receptors and increased production of growth-factor and cytokines. Journal of Rheumatology. 1994;21(8):1507–1511
  78. Espinoza LR, Aguilar JL, Espinoza CG, et al. Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses. Journal of Rheumatology. 1994;21(8):1502–1506
  79. Reece RJ, Canete JD, Parsons WJ, et al. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis and Rheumatism. 1999;42(7):1481–1484
  80. Buckley CD, Pilling D, Lord JM, et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends in Immunology. 2001;22(4):199–204
  81. Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Annals of the Rheumatic Diseases. 2005;64:55–57
  82. Grisar J, Bernecker PM, Aringer M, et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. Journal of Rheumatology. 2002;29(7):1430–1436
  83. Cotten A, Flipo RM, Mentre A, et al. Sapho syndrome. Radiographics. 1995;15(5):1147–1154
  84. Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?. Annals of the Rheumatic Diseases. 1998;57(3):135–140
  85. Maric I, Poljak L, Zoricic S, et al. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. Journal of Cellular Physiology. 2003;196(2):258–264
  86. Dodds RA, Merry K, Littlewood A, Gowen M. Expression of messenger-RNA for Il1-ß, Il6 and Tgf-ß-1 in developing human bone and cartilage. Journal of Histochemistry and Cytochemistry. 1994;42(6):733–744
  87. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis and Rheumatism. 1995;38(4):499–505
  88. Tanno M, Furukawa KI, Ueyama K, et al. Uniaxial cyclic stretch induces osteogenic differentiation and synthesis of bone morphogenetic proteins of spinal ligament cells derived from patients with ossification of the posterior longitudinal ligaments. Bone. 2003;33(4):475–484
  89. Nakamura I, Ikegawa S, Okawa A, et al. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Human Genetics. 1999;104(6):492–497
  90. Boers M, Brooks P, Simon LS, et al. OMERACT: an international initiative to improve outcome measurement in rheumatology. Clinical and Experimental Rheumatology. 2005;23(5):S10–S13
  91. Fransen J, Speyer I, Moens HB, van Riel PLCM. The effectiveness of systematic monitoring of RA disease activity in daily practice (TRAC): a multicentre cluster-RCT. Annals of the Rheumatic Diseases. 2004;63:84
  92. van Riel PLCM, Fransen J. To be in remission or not: is that the question?. Annals of the Rheumatic Diseases. 2005;64(10):1389–1390
  93. Pando JA, Duray P, Yarboro C, et al. Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis. Journal of Rheumatology. 2000;27(8):1848–1854
  94. Smolen JS, Han C, Bala M, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement - a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis and Rheumatism. 2005;52(4):1020–1030
  95. Rau R, Sander O, Wassenberg S. Erosion healing in rheumatoid arthritis after anakinra treatment. Annals of the Rheumatic Diseases. 2003;62(7):671–673
  96. Sharp JT, van der Heijde D, Boers M, et al. Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT subcommittee on healing of erosions. Journal of Rheumatology. 2003;30(5):1102–1107
  97. van der Heijde D, Landewe R. Imaging: do erosions heal?. Annals of the Rheumatic Diseases. 2005;62:ii10–ii12
  98. Vukicevic S, Basic V, Rogic D, et al. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. Journal of Clinical Investigation. 1998;102(1):202–214
  99. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-ß 1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Medicine. 2003;9(7):964–968
  100. Cho HJ, Kim HS, Lee MM, et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation. 2003;108(23):2918–2925
  101. Rabelink TJ, de Boer HC, de Koning EJP, van Zonneveld AJ. Endothelial progenitor cells: more than an inflammatory response?. Arteriosclerosis Thrombosis and Vascular Biology. 2004;24(5):834–838
  102. Marinova-Mutafchieva L, Taylor P, Funa K, et al. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis and Rheumatism. 2000;43(9):2046–2055
  103. Marinova-Mutafchieva L, Williams RO, Funa K, et al. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis and Rheumatism. 2002;46(2):507–513
  104. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. International Journal of Biochemistry and Cell Biology. 2004;36(4):568–584
  105. Jorgensen C, Gordeladze J, Noel D. Tissue engineering through autologous mesenchymal stem cells. Current Opinion in Biotechnology. 2004;15(5):406–410
  106. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine. 2004;8(3):301–316
  107. Luyten FP. Mesenchymal stem cells in osteoarthritis. Current Opinion in Rheumatology. 2004;16(5):599–603
  108. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New England Journal of Medicine. 1994;331(14):889–895
  109. Peterson L, Minas T, Brittberg M, et al. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clinical Orthopaedics and Related Research. 2000;374:212–234
  110. Brittberg M, Tallheden T, Sjogren-Jansson E, et al. Autologous chondrocytes used for articular cartilage repair – an update. Clinical Orthopaedics and Related Research. 2001;391:S337–S348
  111. Bentley G, Biant LC, Carrington RWJ, et al. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. Journal of Bone and Joint Surgery. British Volume. 2003;85B(2):223–230
  112. Knutsen G, Engebretsen L, Ludvigsen TC, et al. Autologous chondrocyte implantation compared with microfracture in the knee – a randomized trial. Journal of Bone and Joint Surgery. American Volume. 2004;86A(3):455–464
  113. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis and Rheumatism. 2003;48(12):3464–3474

PII: S1521-6942(06)00080-5

doi: 10.1016/j.berh.2006.06.009

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 829-848 , October 2006

Article Tools

* Image Usage & Resolution